Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|July 5, 2008
Recent advances in the discovery of 11beta-HSD1 inhibitorsCraig D BoyleCurrent Topics in Medicinal Chemistry|May 29, 2003
Structure-activity relationship studies: M2 and CCR5 receptor antagonistsCraig D Boyle, Anandan PalaniExpert Opinion on Therapeutic Patents|May 22, 2009
11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patentsCraig D Boyle, Timothy J KowalskiBioorganic & Medicinal Chemistry Letters|July 24, 2009
The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitorsSanthosh F Neelamkavil, Craig D Boyle, Samuel Chackalamannil, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitorsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.The Journal of Organic Chemistry|February 16, 2002
Synthesis of mono- and difluoronaphthoic acidsJayaram R Tagat, Stuart W McCombie, Dennis V Nazareno, et al.Bioorganic & Medicinal Chemistry Letters|June 20, 2008
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonistsUnmesh Shah, Craig D Boyle, Samuel Chackalamannil, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunctionDmitri A Pissarnitski, Theodros Asberom, Craig D Boyle, et al.Journal of Medicinal Chemistry|December 3, 2002
Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonistsYuguang Wang, Samuel Chackalamannil, Zhiyong Hu, et al.Pageof 2